|
|
||||||||
State University of New York at Buffalo School of Medicine and Biomedical Sciences and Graduate School, Department of Internal Medicine, Buffalo General Hospital/Kaleida Health System, Buffalo, New York 14203
1To whom requests for reprints should be addressed at SUNYABBuffalo General Hospital/Kaleida Health System, 100 High Street, Room E-320, Buffalo, NY 14203. E-mail: jlambrus{at}netscape.net
In a previous issue of Experimental Biology and Medicine, we published a Minireview (1) on the role of nutrition in infectious disease and related problems in acquired immunodeficiency syndrome (AIDS). We summarized our experience and previous publications. We pointed out that both caloric and micronutrient deficiency increased the severity of AIDS in patients. We made similar observations in relation to an animal model of AIDS. It was suggested that improving nutrition, particularly micronutrition (vitamins, minerals) may be the most efficient contribution to infectious diseaserelated morbidity and mortality in developing countries; it may also increase the efficacy of vaccination programs. This may have special value in treating AIDS. Since this Minireview was submitted, an article by Fawzi et al. (2) and an editorial by Marston and De Cock (3) have appeared in the New England Journal of Medicine indicating that, in a study of 1078 pregnant women in Tanzania, multivitamin supplementation significantly decreased progression of HIV infectioninduced disease in more than 1000 pregnant patients. More detailed studies, particularly in other tropical diseases, appear to be well justified.
Another report, by Foster (4), which has appeared since the submission of our Minireview, pointed out that HIV-1 encodes the homologue of one of the human glutathione peroxidases at the expense of the host; this results in deprivation of its four basic components: selenium, cysteine, glutamine, and tryptophan. In a preliminary study in Botswana, supplementation with these components resulted in improvement of the status of AIDS patients, as quoted by the report (without giving actual data).
Footnotes
This work was supported in part by the National Institutes of Health, The John R. Oishei Foundation, and the Margaret Duffy and Cameron Troup Fund for Cancer Research.
References
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |